Meyka Pro banner
Bausch + Lomb Corporation

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

BLCO●NYSE
HealthcareMedical - Instruments & Supplies
$20.40
$0.00(0.00%)
U.S. Market opens in 16h 3m

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

Bausch + Lomb Corporation (NYSE: BLCO) shows moderate financial fundamentals with a PE ratio of -64.46, profit margin of -1.15%, and ROE of -0.97%. The company generates $5.4B in annual revenue with moderate year-over-year growth of 6.47%.

Key Strengths

PEG Ratio-0.71
Current Ratio1.55

Areas of Concern

ROE-0.97%
Operating Margin8.41%
We analyze BLCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 24.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
24.9/100

We analyze BLCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLCO struggles to generate sufficient returns from assets.

ROA > 10%
-0.45%

Valuation Score

Excellent

BLCO trades at attractive valuation levels.

PE < 25
-64.46
PEG Ratio < 2
-0.71

Growth Score

Moderate

BLCO shows steady but slowing expansion.

Revenue Growth > 5%
6.47%
EPS Growth > 10%
-13.33%

Financial Health Score

Excellent

BLCO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.80
Current Ratio > 1
1.55

Profitability Score

Weak

BLCO struggles to sustain strong margins.

ROE > 15%
-96.75%
Net Margin ≥ 15%
-1.15%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLCO Expensive or Cheap?

P/E Ratio

BLCO trades at -64.46 times earnings. This suggests potential undervaluation.

-64.46

PEG Ratio

When adjusting for growth, BLCO's PEG of -0.71 indicates potential undervaluation.

-0.71

Price to Book

The market values Bausch + Lomb Corporation at 1.12 times its book value. This may indicate undervaluation.

1.12

EV/EBITDA

Enterprise value stands at 3.45 times EBITDA. This is generally considered low.

3.45

How Well Does BLCO Make Money?

Net Profit Margin

For every $100 in sales, Bausch + Lomb Corporation keeps $-1.15 as profit after all expenses.

-1.15%

Operating Margin

Core operations generate 8.41 in profit for every $100 in revenue, before interest and taxes.

8.41%

ROE

Management delivers $-0.97 in profit for every $100 of shareholder equity.

-0.97%

ROA

Bausch + Lomb Corporation generates $-0.45 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.45%

Following the Money - Real Cash Generation

Operating Cash Flow

Bausch + Lomb Corporation generates limited operating cash flow of $457.83M, signaling weaker underlying cash strength.

$457.83M

Free Cash Flow

Bausch + Lomb Corporation generates weak or negative free cash flow of $140.16M, restricting financial flexibility.

$140.16M

FCF Per Share

Each share generates $0.39 in free cash annually.

$0.39

FCF Yield

BLCO converts 1.96% of its market value into free cash.

1.96%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-64.46

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.71

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.12

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.80

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.55

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How BLCO Stacks Against Its Sector Peers

MetricBLCO ValueSector AveragePerformance
P/E Ratio-64.4631.76 Better (Cheaper)
ROE-0.97%543.00% Weak
Net Margin-1.15%5160.00% Weak
Debt/Equity0.800.07 Weak (High Leverage)
Current Ratio1.555.73 Neutral
ROA-0.45%-182.00% (disorted) Weak

BLCO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bausch + Lomb Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

47.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1878.52%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-46.37%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ